Reassessing the 1+1 pneumococcal conjugate vaccine schedule

被引：1
作者：
Perniciaro, Stephanie [1 ]
van der Linden, Mark [1 ]
机构：
[1] Rhein Westfal TH Aachen, Dept Med Microbiol, German Natl Reference Ctr Streptococci, Univ Hosp, D-52074 Aachen, Germany
来源：
LANCET INFECTIOUS DISEASES | 2018年 / 18卷 / 04期
关键词：
D O I：
10.1016/S1473-3099(18)30129-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：381 / 382
页数：3
相关论文
共 5 条
  • [1] Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+1) compared with two primary doses and a booster (2+1) in UK infants: a multicentre, parallel group randomised controlled trial
    Goldblatt, David
    Southern, Jo
    Andrews, Nick J.
    Burbidge, Polly
    Partington, Jo
    Roalfe, Lucy
    Pinto, Marta Valente
    Thalasselis, Vasilli
    Plested, Emma
    Richardson, Hayley
    Snape, Matthew D.
    Miller, Elizabeth
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (02) : 171 - 179
  • [2] Joint Committee on Vaccination and Immunisation, 2017, M 04 OCT
  • [3] When less is more: how many doses of PCV are enough?
    O'Brien, Katherine L.
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (02) : 127 - 128
  • [4] Russell FM, 2011, GLOBAL REV DISTRIBUT
  • [5] Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review
    Saokaew, Surasak
    Rayanakorn, Ajaree
    Wu, David Bin-Chia
    Chaiyakunapruk, Nathorn
    [J]. PHARMACOECONOMICS, 2016, 34 (12) : 1211 - 1225
1